Why some of America's biggest brands are losing ground in China

CNBC reports that American brands are losing ground in China as domestic competition accelerates and tariff-driven geopolitical tensions erode demand for U.S. products. Nike’s China business shrank ~30% since 2021 and is at its lowest level in eight years, while GM’s China earnings fell from ~US$2B annually in 2018 to consecutive losses in 2024 and 2025. The article also notes China’s EV share rose to 65.1% of new passenger-car sales in July (from 54% a year earlier), intensifying pressure on U.S. automakers; amid these challenges, several firms are restructuring, partnering locally, or considering options for China operations.

Analysis

The market is still underestimating how much of this is a margin-and-multiple story rather than a pure revenue story. In China, brands that rely on imported cachet are losing pricing power at the same time local players are compressing product cycles and distribution costs; that creates a double hit to EBIT margins and a longer-duration de-rating for names like NKE, SBUX, GM and parts of PG. The immediate risk is further estimate cuts, but the bigger second-order effect is that weak China returns reduce management willingness to reinvest there, which can turn into a self-fulfilling share-loss loop over the next 2-4 quarters.

The relative winners are the companies that can localize fast or that facilitate localization. RL and BZUN fit that bucket: one has a cleaner premium proposition that appears to resonate, the other benefits when global brands outsource China execution instead of doing it in-house. On the competitive side, domestic brands such as LKNCY and BYDDY are not just taking share in China; they are building operating leverage and export capability that can pressure incumbents in Europe and Latin America over 6-18 months. That creates an asymmetric problem for F/GM/STLA: even if China is no longer a headline growth engine, Chinese EV competition is now a global pricing constraint.

Contrarian view: the consensus is treating all China exposure as fungible, but the winners are being selected by execution, not nationality. That means blanket de-risking may be overdone for names with local product-market fit and underdone for those with structurally weak channel economics. Falsifiers are simple: any sustained re-acceleration in China comps, gross margin stabilization, or management explicitly lifting China guidance over the next two earnings cycles would break the short thesis; absent that, the trend likely persists into 2026.

Key Decisions for Investors

• Short NKE vs long RL into the next 1-2 earnings windows: RL has visible China momentum while NKE still faces the burden of rebuilding distribution and pricing power; target 15-20% relative outperformance for RL if China comps stay divergent.
• Short SBUX / long LKNCY as a China coffee price-war pair trade for 3-6 months: Luckin's scale and discount architecture remain the cleaner beneficiary unless Starbucks proves its JV can re-accelerate same-store sales.
• Short GM or F against BYDDY on a 6-12 month horizon: BYD's export channel is the second-order winner from China overcapacity, while GM faces both domestic China erosion and emerging global EV price pressure.
• Speculative long BZUN on any pullback: if more U.S. brands outsource China operations, BZUN is a beneficiary of the localization trend; invalidation is a lack of follow-on partnerships or no improvement in operating leverage over 2 quarters.
• Avoid bottom-fishing NKE/SBUX until China guidance inflects: the trade needs either a comp sales floor or evidence of regained local share; otherwise earnings revisions can continue for another 1-3 quarters.